• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Biogen Inc. (BIIB)

    -NasdaqGS
    429.87 Up 0.94(0.22%) Mar 27, 4:00PM EDT
    |After Hours : 429.00 Down 0.87 (0.20%) Mar 27, 7:59PM EDT
    Add to Portfolio
    Prev Close:428.93
    Open:430.12
    Bid:N/A
    Ask:429.12 x 100
    1y Target Est:474.98
    Beta:0.62
    Earnings Date:Apr 21 - Apr 27 (Est.)
    Day's Range:429.36 - 436.67
    52wk Range:272.02 - 480.18
    Volume:1,859,181
    Avg Vol (3m):1,899,970
    Market Cap:100.85B
    P/E (ttm):34.75
    EPS (ttm):12.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for BIIB

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 0.22%100.85B
    PFEUp 1.08%211.63B

    Key Statistics

    Forward P/E (1 yr):21.58
    P/S (ttm):10.37
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :16.98
    Quarterly EPS Est (Mar-15) :3.91
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):1.43

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback